Open AccessKidney transplantation from a hepatitis C virus-positive donor to a hepatitis C virus-negative recipient
Author(s) -
M Kamalkiran,
V Ravikiran,
C Shashidhar,
Kaleshwer Prasad,
Vijay Yeldandi
Publication year - 2018
Publication title -
indian journal of nephrology/indian journal of nephrology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.317
H-Index - 24
eISSN - 1998-3662
pISSN - 0971-4065
DOI - 10.4103/ijn.ijn_267_17
Subject(s) - medicine , sofosbuvir , ribavirin , hepatitis c virus , transplantation , kidney transplantation , basiliximab , liver transplantation , immunosuppression , hepatitis c , gastroenterology , cirrhosis , prednisolone , immunology , virus
Kidney transplantation from a hepatitis C virus (HCV)-positive donor to an HCV-negative recipient till recently has been a contraindication. In view of the excellent sustained virological response (SVR) rates with directly acting antiviral agents, HCV-positive donors are being considered for the HCV-negative recipients in a few centers. We report the successful transplantation of an HCV-negative recipient transplanted with an HCV-positive donor kidney. Donor was treated with sofosbuvir and ribavirin for 12 weeks. At 10 th and 16 th weeks of starting treatment, her HCV-RNA PCR was negative. Three weeks later, transplantation was performed with basiliximab induction and triple immunosuppression with tacrolimus, mycophenolate, and prednisolone. The recipient was administered sofosbuvir and ribavirin for 12 weeks. He attained good graft function with a stable creatinine. His serial alanine transaminases were normal on 3 rd , 6 th , and 12 th months, respectively. Six months posttransplant his anti-HCV antibody, and HCV-RNA PCR were negative.